Electro-Optical Sciences (MELA) Said FDA Accepts Application For MelaFind
Up)
Electro-Optical Sciences, Inc. (NASDAQ: MELA) announced today that the FDA formally accepted for filing the company's Pre-Market Approval (PMA) application for MelaFind, a non-invasive and objective computer vision system intended to aid in the early detection of melanoma.
The FDA's action means that the PMA application was sufficiently complete and ready for substantive review. The filing date for regulatory purposes is June 9, 2009, the date the FDA received EOS' PMA submission. The FDA also confirmed that the PMA application will receive expedited review and processing.
The FDA's action means that the PMA application was sufficiently complete and ready for substantive review. The filing date for regulatory purposes is June 9, 2009, the date the FDA received EOS' PMA submission. The FDA also confirmed that the PMA application will receive expedited review and processing.
You May Also Be Interested In
- Unusual 11 Mid-Day Movers 05/23: (SCHS) (AMBT) (PCX) Higher; (DELL) (EGLE) (GENE) Lower
- Catalyst Pharmaceutical (CPRX) Reports Encouraging Data from CPP-115 Phase Ia
- Morning Movers 05/23: (SCHS) (MELA) (PETM) Higher; (DELL) Lower
Create E-mail Alert Related Categories
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
